These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34900749)

  • 1. Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():801970. PubMed ID: 34900749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():721644. PubMed ID: 34631549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():979968. PubMed ID: 36072794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.
    Zhang T; Nie Y; Gu J; Cai K; Chen X; Li H; Wang J
    Front Oncol; 2021; 11():843623. PubMed ID: 35111689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
    Hu X; Bao M; Huang J; Zhou L; Zheng S
    Front Oncol; 2020; 10():617539. PubMed ID: 33330112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.
    Han C; Chen J; Huang J; Zhu R; Zeng J; Yu H; He Z
    Front Oncol; 2023; 13():1162375. PubMed ID: 36969048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.
    Che L; Paliogiannis P; Cigliano A; Pilo MG; Chen X; Calvisi DF
    Front Oncol; 2022; 12():874053. PubMed ID: 35494002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
    Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
    Front Oncol; 2023; 13():1134139. PubMed ID: 37025598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: a multicenter study.
    Wang J; Zheng T; Liao Y; Geng S; Li J; Zhang Z; Shang D; Liu C; Yu P; Huang Y; Liu C; Liu Y; Liu S; Wang M; Liu D; Miao H; Li S; Zhang B; Huang A; Zhang Y; Qi X; Chen S
    Front Oncol; 2023; 13():1278295. PubMed ID: 37719010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: A Weighted Gene Co-Expression Network Analysis-Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer.
    Chen Q; Tan Y; Zhang C; Zhang Z; Pan S; An W; Xu H
    Front Oncol; 2021; 11():683333. PubMed ID: 33937088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma.
    Váncza L; Karászi K; Péterfia B; Turiák L; Dezső K; Sebestyén A; Reszegi A; Petővári G; Kiss A; Schaff Z; Baghy K; Kovalszky I
    Front Oncol; 2023; 13():1203745. PubMed ID: 37152016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Review of novel functions and implications of circular RNAs in hepatocellular carcinoma.
    Liu Z; Yang F; Xiao Z; Liu Y
    Front Oncol; 2024; 14():1380699. PubMed ID: 38469230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.
    Zhang K; Liu H; Yu M; Zhao H; Yang N; Bi X; Sun L; Lin R; Lü G
    Front Oncol; 2021; 11():785394. PubMed ID: 34722323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Heparin binding epidermal growth factor-like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma.
    Van Hiep N; Sun WL; Feng PH; Lin CW; Chen KY; Luo CS; Dung LN; Van Quyet H; Wu SM; Lee KY
    Front Oncol; 2022; 12():1106553. PubMed ID: 36582792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator.
    Li X; Yuan Y; Pal M; Jiang X
    Front Oncol; 2022; 12():972329. PubMed ID: 35957918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Prediction of Microvascular Invasion and Its M2 Classification in Hepatocellular Carcinoma Based on Nomogram Analyses.
    Chen S; Wang C; Gu Y; Ruan R; Yu J; Wang S
    Front Oncol; 2022; 12():888008. PubMed ID: 35449582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA.
    Yang W; Li Z; Qin R; Wang X; An H; Wang Y; Zhu Y; Liu Y; Cai S; Chen S; Sun T; Meng J; Yang C
    Front Oncol; 2021; 11():828861. PubMed ID: 35096629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
    Lai Y; Feng B; Abudoureyimu M; Zhi Y; Zhou H; Wang T; Chu X; Chen P; Wang R
    Front Oncol; 2020; 10():277. PubMed ID: 32195187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study.
    Isowa M; Hamaguchi R; Narui R; Morikawa H; Wada H
    Front Oncol; 2023; 13():1291026. PubMed ID: 37799473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis
    Wen J; Aili A; Yan YX; Lai Y; Niu S; He S; Zhang X; Zhang G; Li J
    Front Oncol; 2022; 12():1038279. PubMed ID: 36387066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.